INTRODUCTION
Microglia plays a crucial role as the first line of defense when neuronal damage occurs.
Under normal conditions microglial cells are in a state of surveillance with elongated processes. During injury or neurodegenerative processes, microglial cells become activated; the activated state is mirrored by up regulation of translocator protein (TSPO) (1, 2) . Positron emission tomography (PET) with TSPO specific ligands provide an in vivo technique to detect microglial activation (3). 11 C-(R)-PK11195 PET has been used for more than two decades. However, due to low signal-to-background ratio and short half-life (20 min), second generation TSPO markers have been developed. These include 18 F-FEPPA, 18 F-FEDAA1106, 11 C-vinpocetine, 11 C-DAC, 11 C-DAA1106, 11 C-N1-methyl-2-phenylindol-3-ylglyoxylamide , 11 C-CLINME, 11 C-DPA-713, 18 F-DPA-714, 18 F-PBR06 and 11 C-PBR28 (4). However, the results obtained by second generation radioligands in pre-clinical models have not been consistently reproduced in humans (5) . Their quantification in humans suffers from three confounding factors (6) . The first factor is genetic: a single nucleotide polymorphism in the TSPO gene (rs6971) leads to an amino-acid substitution (A147T) and reduced binding affinity. The second factor is the disproportion between the high signal from the TSPO in the endothelial cells of the blood-brain barrier (BBB) and venous sinuses and the signal from the tissue, requiring appropriate kinetic correction (7) . The third factor is the difficulty in obtaining accurate estimates of free plasma concentrations for proper quantification.
Flutriciclamide ( 18 F-GE180) has been identified as a promising TSPO tracer in preclinical models of stroke and lipopolysaccharide (LPS)-induced central nervous system inflammation (8, 9) . Here we report the results of a study evaluating 18 F-GE180 PET in healthy human brains. We have investigated: 1) blood tracer concentrations 2) brain uptake 3) quantification of binding via tracer kinetic modeling 4) optimal scan length and 5) feasibility of generating parametric maps.
MATERIALS AND METHODS
Fifteen HC aged 50-85 were recruited. Subjects who were high (HABs=6) or mixed affinity binders (MABs=4) proceeded to MRI and PET scans, while low affinity binders (LABs=5)
were excluded. Details of recruitment, demography, and MRI acquisition in Supplementary file 1.
GE180 PET
18 F-GE180 was manufactured on the GE FASTlab (10). All subjects received 185 MBq 18 F-GE180 by bolus intravenous injection (in 20 seconds) immediately before the PET scan. The scan was acquired using a Siemens Biograph 6 PET/CT scanner (11) . An initial CT was acquired for patient position and for attenuation correction of PET images. The tracer was then injected and dynamic emission PET images were acquired over 210 minutes using predetermined time frames: 6x15s, 3x60s, 5x120s, 5x300s, and 14x600s.
Images were corrected for attenuation, random and scattered emissions based on the 3D
ordinary Poisson ordered-subset expectation maximization algorithm. Reconstruction of PET was carried out using filtered back projection.
Blood data
Arterial whole blood activity was continuously monitored for the first 15 min of the PET scan using the Allogg automated blood sampling system (ABSS) with real-time online blood sampling. Ten discrete arterial blood samples were taken at 5, 10, 15, 30, 60, 90, 120, 150, 180 and 210 min of the PET scan. The activity concentration was measured in both whole blood and plasma by a well counter and was used to generate a plasma:blood ratio curve. Applying the plasma:blood ratio model to the first 15 min of continuous whole blood data, the time course of activity in the plasma can be estimated with a sigmoidal fitting.
Metabolites of 18 F-GE180 were measured by HPLC (High-performance liquid chromatography) analysis (10) using discrete blood samples. A two-exponential linear model was used to describe the parent fraction of 18 F-GE180, which was applied to the plasma to generate the parent plasma input function. Standardized uptake value (SUV) was applied to both total blood and parent plasma with the formula:
Finally, the time delay (the arrival of the 18 F-GE180 bolus at the peripheral sampling site) was determined using MICK.exe (Quantitative software for the PET analysis) and were performed based on MATLAB®2014 (The MathWorks, USA) on Windows platform.
Region of interest analysis
Each subject underwent two 90 min PET scans with a 20 min break in between; the realignment approach was necessary to re-align the second scan to the first scan. Head motions were corrected using the frame-by-frame realignment tools in Statistical Parametric Mapping (SPM). Based on the visual resolution, the 8 th frame (185-245s) was selected as the reference frame for each time frame realigning to. An individualized object map in PET space was created with the following procedure: 1) MRI was co-registered to the PET add image (60 -90 min); 2) a binary grey and white matter mask was created via segmentation; 3) the probabilistic ROI atlas (12) in MNI space was transformed into native PET space; 4) we applied the binary mask to the ROI atlas to generate individual ROIs.
Regional time activity curves (TACs) were generated by sampling the dynamic PET images with the individual ROIs for the following merging regions: frontal, temporal, parietal, occipital lobes and whole brain. Additional sampling of posterior cingulate, thalamus, brainstem, whole medial temporal lobe, hippocampus, and cerebellum was performed. The parahippocampus, anterior cingulate and amygdala were sampled as additional ROIs using Analyze 11.0. The SUV TAC was generated for each 18 F-GE180 dynamic PET by dividing the ratio of 18 F-GE180 injected dose over body weight.
Kinetic modeling
Parent plasma input function and dynamic PET were used to investigate the best kinetic model to compute 18 with the smallest AIC value should be selected as the preferred model, as it indicates the best fit (16) . In order to select the best model to quantify the tracer, AIC is calculated using the following formula:
where m denotes number of parameters, n equals the sum of degrees of freedom and number of parameters, wrss denotes weighted residual sum of squares (17) . The AIC fraction was also calculated by measuring the frequency of AIC preferences for each model across all subjects (18) . AIC was calculated for the following brain regions: frontal, temporal, parietal, occipital lobes, whole brain, posterior-cingulate, thalamus, striatum, brainstem, medial-temporal-lobe, hippocampus and cerebellum. Coefficient of variation (CV) was measured to assess dispersion and precision of parameters. We also evaluated the separation in average binding between high and mixed affinity binder classes.
Graphical analysis
Graphical analysis was applied to investigate the feasibility of generating parametric maps of 18 F-GE180. Logan or Patlak plot were involved based on the nature of the tracer (reversible or irreversible). Initially we calculated the optimal threshold time by linear fit the tissue:plasma ratio against the time. 18 F-GE180 parametric maps were generated with the parent plasma input function and dynamic PET images using MICK parametric map software on MATLAB.
Optimisation of scan length
The optimum scan duration was evaluated measuring the percentage change of k (rate constants) and VT, along with their CV at different time durations, calculated at 60 min, 75 min, 90 min, 150 min, 180 min, and 210 min. k3 and k4 indicate the rate constant of 18 F-GE180 in and out of the specific-bound compartment, while the k3/k4 ratio represents the specific binding of the tracer. Thus, the k3/k4 ratio was measured to investigate whether the binding potential of 18 F-GE180 was affected when the scanning time was reduced.
Statistical analysis
Statistical analysis of group-wise differences between different kinetic models, different scan durations and ROI VT in different genetic groups was calculated in SPSS for Windows version 22 (SPSS, Chicago, Illinois, USA). A p value of <0.05 was regarded as a statistical difference. The Pearson correlation was applied to measure the linear correlation between two groups of variables using SPSS22. Repeated measures ANOVA (analysis of variance) was applied to detect any overall differences between repeated measurements.
RESULTS

Parent plasma input
Consistent with the preclinical work (8), the radiochromatogram revealed three identifiable radiolabeled metabolites and a parent 18 F-GE180 in human plasma (Fig.1A) . The parent fraction of 18 F-GE180 gradually reduced from 90% to 60%. There was no group difference between HABs and MABs in metabolic rates and plasma:blood curve (Fig.1B and Fig.1C ).
The 18 F-GE180 activity concentration in plasma was 1.6-fold higher than in whole blood.
No difference in parent plasma input function between HABs and MABs was found (Fig.1D ).
Dynamic PET image TAC
As tracer concentrations are correlated with injected dose and individual weight, we measured SUV TAC values at each time frame. The tracer activity concentration in the brain peaked at 125 seconds with SUV at 1.5 and then quickly washed out and reached a plateau around 40 min. As a group, SUVs were significantly higher in HABs than MABs in temporal lobe (p=0.0001), thalamus (p=0.0001) and striatum (p=0.0002) (Fig.2) . The venous sinuses showed consistently highest tracer activity throughout the scan, while grey matter showed around 30% higher activity concentration than white matter.
Kinetic modeling
Among five kinetic models, two-tissue reversible model (2TCM4k) showed the lowest AIC value in frontal (-59.6±5.4), temporal (-46.4±4.5), parietal (-58.6±5.4) and occipital lobes (-54.3±5.1) as a group (Fig 3A) . 2TCM4k model also showed the highest AIC fraction ( Fig   3B) . While the 2TCM3k irreversible model demonstrated closer AIC values (less than 10%
difference compared to 2TCM4k model), the ki (net influx constant), demonstrating the overall net rate of tracer uptake into tissue in 2TCM3k model, showed poor precision with high coefficient of variation (CV=104±85%) while VT in reversible 2TCM4k had a CV of 21±13%. Based on the model curve fitting, 2TCM4k provided a good fit to 18 F-GE180 activity, supported by smallest weighted residual sum square and more random in residual's sequence (similar number of residuals above or below the model curve) using
Wald-Wolfowitz test. In summary, the 2TCM4k is the preferred method of analysis of 18 F-GE180 PET. Supplementary file 3 details rate constants (K1, k2, k3 and k4), blood volume and VT applying the 2TCM4k model in HABs and MABs which showed good precision of parameter estimation.
Volume of distribution
As a group, ten HC had low mean VT in whole brain, but slightly higher in temporal lobe, occipital lobe and thalamus (Fig.4) . Thalamus, parahippocampus, and cerebellum showed significantly higher mean VT values in HABs compared with MABs (Table 1) .
Scan length
210 min data was excluded as variance was very high towards the end of the scan. Repeated ANOVA did not show difference in the absolute VT when reducing the scan duration. In this study, the group mean of k3/k4 ratio (HAB=0.52 and MAB=0.34) was calculated to evaluate the results among different scan lengths, showing no differences with scan length reduction from 180 min to 90 min. When the scan length was further reduced to 75 min, the k3/k4 ratio remained the same as with the 90 min data, but four individual subjects showed a 14% reduction in k3/k4 ratio. Compared to 90 min scans, 60 min scans showed a 51% reduction in k3/k4 ratio as a group. These data suggest that for this cohort the optimal scan duration is 90 min.
LOGAN
Kinetic modelling suggested that 18 F-GE180 has a reversible feature, therefore we applied Logan graphical analysis (19) (Fig. 6) . The HABs showed generally higher Logan VT values than MABs; however, there were no statistically significant differences in this small sample.
DISCUSSION
This is the first study evaluating different approaches for PET modelling of the third generation TSPO tracer 18 F-GE180 in older healthy subjects, establishing the optimum scanning time in this study population. There was consistently higher Preclinical animal models showed that 18 F-GE180 crosses the BBB readily. In humans, 18 F-GE180 demonstrated a relatively low VT in the brain, possibly due to: 1) low availability of the GE180 due to significant plasma protein binding, 2) low BBB permeability or 3) clearance by efflux pumps. Despite the fact that species differences have been observed in the BBB structure (20) and other novel brain PET tracers (21), the significant difference observed between human and preclinical models in 18 F-GE180 could be primarily due to a significantly higher binding to plasma protein in humans. 18 F-GE180 preclinical studies demonstrated that, in rats, there is a clear regional differentiation of high TSPO expressing regions (olfactory bulbs) compared to low TSPO expressing regions (striatum) (22) . In this study, five subjects (1 MAB and 4 HABs) revealed lowest uptake in striatum, three (MABs) showed lowest uptake in cerebellum, two (HABs) showed a more generalized distribution of TSPO expression. This inconsistent pattern suggests that a single predefined reference region for non-specific binding may not be appropriate for 18 F-GE180 in humans in this age group.
As TSPO expression is low in healthy brain, the 18 marker cannot be determined until we have results in specific disease conditions. The significant inverse correlation between the 18 F-GE180 input function and the VT in brain suggests reflects the higher uptake to plasma proteins in humans compared to animal models.
Interestingly, the significant inverse correlation between 18 F-GE180 input function and VT in brain for each binding class separately, with a correlation coefficient > 0.9, indicates that whole brain VT can be almost entirely predicted by plasma levels within each binding class.
Given that it was not possible to estimate plasma free fractions reliably, possibly because the fluctuations in estimated VT may be due to fluctuations in free fractions across subjects.
Indeed, higher plasma protein binding would result in higher plasma counts and lower volume of distribution. This observation replicates similar observations in other TSPO tracers (13, 24) . Identification of an optimal reference method would allow us to further refine the analysis methods without the arterial input. 
